Peng X, Yin R, Luo L, Xu S, Shuai Z
J Inflamm Res. 2024; 17:10699-10709.
PMID: 39677284
PMC: 11645955.
DOI: 10.2147/JIR.S488605.
Heutz J, Looijen A, Kuijpers J, Schreurs M, van der Helm-van Mil A, de Jong P
Immunol Res. 2024; 72(5):982-990.
PMID: 38960995
PMC: 11564213.
DOI: 10.1007/s12026-024-09500-w.
Bugatti S, Manzo A, Montecucco C, Caporali R
Front Med (Lausanne). 2018; 5:339.
PMID: 30560132
PMC: 6287017.
DOI: 10.3389/fmed.2018.00339.
Podas T, Nightingale J, Oldham R, Roy S, Sheehan N, Mayberry J
Postgrad Med J. 2007; 83(976):128-31.
PMID: 17308218
PMC: 2805936.
DOI: 10.1136/pgmj.2006.050245.
Ates A, Kinikli G, Turgay M, Akay G, Tokgoz G
Clin Rheumatol. 2006; 26(4):538-45.
PMID: 16804738
DOI: 10.1007/s10067-006-0343-x.
Human IgG Fc-binding phage antibodies constructed from synovial fluid CD38+ B cells of patients with rheumatoid arthritis show the imprints of an antigen-dependent process of somatic hypermutation and clonal selection.
van Esch W, Reparon-Schuijt C, Hamstra H, van Kooten C, Logtenberg T, Breedveld F
Clin Exp Immunol. 2003; 131(2):364-76.
PMID: 12562401
PMC: 1808634.
DOI: 10.1046/j.1365-2249.2003.02068.x.
Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage.
Knijff-Dutmer E, Drossaers-Bakker W, Verhoeven A, van der Sluijs Veer G, Boers M, van der Linden S
Ann Rheum Dis. 2002; 61(7):603-7.
PMID: 12079900
PMC: 1754168.
DOI: 10.1136/ard.61.7.603.
Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells.
van Esch W, Reparon-Schuijt C, Levarht E, van Kooten C, Breedveld F, Verweij C
Clin Exp Immunol. 2001; 123(3):496-504.
PMID: 11298139
PMC: 1906001.
DOI: 10.1046/j.1365-2249.2001.01475.x.
The clinical implications of autoantibody detection in rheumatology.
Charles P, Maini R
J R Coll Physicians Lond. 1993; 27(4):358-62.
PMID: 8289151
PMC: 5396709.
Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis.
Lee S, Bridges Jr S, Kirkham P, Koopman W, Schroeder Jr H
J Clin Invest. 1994; 93(1):361-70.
PMID: 8282807
PMC: 293784.
DOI: 10.1172/JCI116968.
Lymphoid irradiation in intractable rheumatoid arthritis: effects on the production of immunoglobulins and rheumatoid factors.
Hanly J, Hassan J, Moriarty M, Whelan A, Feighery C, Bresnihan B
Clin Exp Immunol. 1985; 62(3):647-56.
PMID: 4085151
PMC: 1577473.
IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.
Gioud-Paquet M, Auvinet M, Raffin T, Girard P, Bouvier M, Lejeune E
Ann Rheum Dis. 1987; 46(1):65-71.
PMID: 3813676
PMC: 1002060.
DOI: 10.1136/ard.46.1.65.
Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis.
Westedt M, Daha M, Baldwin 3rd W, Stijnen T, Cats A
Ann Rheum Dis. 1986; 45(10):809-15.
PMID: 3789816
PMC: 1002001.
DOI: 10.1136/ard.45.10.809.
IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis.
Granfors K, Toivanen A
Ann Rheum Dis. 1986; 45(7):561-5.
PMID: 3740980
PMC: 1001937.
DOI: 10.1136/ard.45.7.561.
Class-specific rheumatoid factors, DR antigens, and amyloidosis in patients with rheumatoid arthritis.
Maury C, Teppo A, Wafin F, Wegelius O, Friman C, Koskimies S
Ann Rheum Dis. 1988; 47(7):546-52.
PMID: 3401051
PMC: 1003568.
DOI: 10.1136/ard.47.7.546.
Heterogeneity in rheumatoid factor isotypes and specificities in MRL mice.
Bond A, Cooke A, Hay F
Immunology. 1988; 64(1):17-21.
PMID: 3384451
PMC: 1385180.
Significance of rheumatoid factors in an eight-year longitudinal study on arthritis.
Tuomi T, Aho K, Palosuo T, Kaarela K, von Essen R, Isomaki H
Rheumatol Int. 1988; 8(1):21-6.
PMID: 3363280
DOI: 10.1007/BF00541346.
Serum IgG4 anti-Fab antibodies in rheumatoid arthritis are constitutively expressed.
Persselin J, Stevens R
Rheumatol Int. 1988; 8(5):205-11.
PMID: 3266356
DOI: 10.1007/BF00269196.
ELISA assays for IgM and IgG rheumatoid factors: their clinical correlations during therapy with slow-acting anti-rheumatic drugs.
Scott D, Dawes P, Collins M, Stone R
Clin Rheumatol. 1987; 6(3):358-68.
PMID: 3127104
DOI: 10.1007/BF02206834.
HLA-DQw7 is a disease severity marker in patients with rheumatoid arthritis.
Stephens H, Sakkas L, Vaughan R, Teitsson I, Welsh K, Panayi G
Immunogenetics. 1989; 30(2):119-22.
PMID: 2569443
DOI: 10.1007/BF02421540.